Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
about
Lower limb progressive resistance training improves leg strength but not gait speed or balance in Parkinson's disease: a systematic review and meta-analysisMethodological issues in using multiple years of the Medicare current beneficiary surveyThe attributable annual health costs of U.S. occupational lead poisoningA pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month resultsPERFORM: a system for monitoring, assessment and management of patients with Parkinson's disease.Non-Linear EMG Parameters for Differential and Early Diagnostics of Parkinson's Disease.Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial.Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.Group patient visits for Parkinson disease: a randomized feasibility trialParkinson's Disease and Home Healthcare Use and Expenditures among Elderly Medicare BeneficiariesClinical predictors of frequent patient telephone calls in Parkinson's disease.A Cross-Sectional Study on Socioeconomic Systems Supporting Outpatients With Parkinson's Disease in Japan.Co-occurring chronic conditions and healthcare expenditures associated with Parkinson's disease: a propensity score matched analysis.The coming crisis: obtaining care for the growing burden of neurodegenerative conditions.National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers.Costs of Parkinson's disease in a privately insured population.Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy.Randomized controlled clinical trial of "virtual house calls" for Parkinson disease.The effects of adapted tango on spatial cognition and disease severity in Parkinson's diseaseSystematic Review and Critical Analysis of Cost Studies Associated with Parkinson's Disease.An economic model of Parkinson's disease: implications for slowing progression in the United States.Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.Virtual visits for Parkinson disease: A multicenter noncontrolled cohort.Estimating the direct and indirect costs associated with Parkinson's disease.Projection of the prevalence of Parkinson's disease in the coming decades: Revisited.Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis.Integrating Patient Concerns into Parkinson's Disease Management.Can Valproic Acid Regulate Neurogenesis from Nestin+ Cells in the Adult Midbrain?Shaking Up the Debate: Ensuring the Ethical Use of DBS Intervention Criteria for Mid-Stage Parkinson's Patients.New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.Economic burden of amyotrophic lateral sclerosis: a Canadian study of out-of-pocket expenses.The current and projected economic burden of Parkinson's disease in the United States.Estimating the economic burden of racial health inequalities in the United States.Using Medical Claims Analyses to Understand Interventions for Parkinson Patients.Experiences of caregivers of people with Parkinson's disease in Singapore: a qualitative analysis.MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.A longitudinal study of economic pressure among people living with a progressive neurological illness.Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany.Parameters of Surface Electromyogram Suggest That Dry Immersion Relieves Motor Symptoms in Patients With Parkinsonism
P2860
Q27016128-C039E38F-8467-4DA2-924A-AFC8C59C1821Q27691813-4FD9D039-8E2D-46DC-9D0A-31B121A843C4Q28386648-9BB8A900-2E3D-44C9-9C18-FD945DF336C9Q30407150-42FB6990-1A40-4905-A775-73D158E17E74Q30420847-F377A585-C9D4-4362-850F-52029F59D13CQ30449049-29F5EF75-E497-481E-AEF4-33D0DA6F95C3Q30614191-B5E59CCE-7E82-441C-A8DE-4865BE946043Q33529426-58A95C01-9A22-45BD-96C1-5ED5386DA706Q34999344-09F47E98-20E0-4CA4-BE4C-FCE95577CC23Q35690721-9F70D96C-DAEF-4DB0-9B28-B0CF4E79A5E3Q36728875-7F2EB4A5-AF37-4D3F-88C6-67D91D5768E9Q36731574-D87C1AE6-43D9-4A7C-816B-316D5EF9B25AQ36976631-3E6246DE-B287-4561-B6A4-1F666F5D05FFQ37027148-2600110F-2782-46AE-A187-F8F73D637469Q37081102-8270D7AB-EEA0-4364-AA17-C7E045967131Q37132304-62E06D2A-1021-4D58-B531-1FF774A29A83Q37172826-03BDFAFD-C51B-4912-9328-40239F35145FQ37217800-2B1597E3-4664-47FF-89D9-4B60B64C1737Q37394420-BFDA7A36-7752-47D0-BA82-844152F9AA47Q37710224-3E35B875-8126-4C0C-AAB9-2BFE8310F374Q38081100-746B0EDA-0697-4666-941D-8D77D334C8AAQ38122127-224926F2-0275-40DB-BC33-458D9157A6EBQ38371677-0AD8DDEC-629D-4867-9E2B-C53DA68486DEQ38618871-064CD012-F9C7-4C0C-972F-DED4CAE13A10Q38673735-32823830-768E-4335-9208-A278561AA958Q38950746-D390146C-9605-47B0-91A7-234B54F91AB9Q39094808-24AE22C8-A867-446F-ABC7-0F15B9A997DFQ39156635-0A62B08C-3FF5-4C1D-AA63-BCD9FD8CA612Q39301896-B4FE688B-DC55-4F7A-996B-FDFA7EFF1272Q39323947-D9E3EDF3-2217-4D1C-BA73-E80FC31DC136Q44317416-42862FDA-D6E1-489A-B049-F4AB84DBE3F0Q44988421-235DB34A-CB99-43D4-A500-DC4F8D5A08B0Q45757050-73DA93D5-3442-4D28-AE43-CEFF42B3BF66Q47288856-7A04901C-FFEF-4280-B24B-DDC851F470B1Q47392450-2A2BB357-69BD-4727-8B2E-44D9D7A1474BQ48483209-2A4D2D2E-F936-434C-8E15-78D144B32702Q49099292-0491BC65-FC49-4B0C-B43A-936AF4E20ACDQ51143314-EEC83BAC-456B-4D6A-A423-CD38C267326FQ57491522-F308BE8E-ECD0-47AF-AB67-A4457B7DE9DC
P2860
Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
@en
Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
@nl
type
label
Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
@en
Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
@nl
prefLabel
Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
@en
Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
@nl
P2093
P2860
P356
P1433
P1476
Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
@en
P2093
Andrew W Dick
Hangsheng Liu
Katia Noyes
Robert Holloway
P2860
P304
P356
10.1002/MDS.20727
P407
P577
2006-03-01T00:00:00Z